Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - ACCOUNTS PAYABLE
Accounts Payable TRVI - Trevi Therapeutics, Inc.
1.81 M
LAST VALUE
-20.32%
2 YEAR CAGR
24.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR